Bilirubin and biliverdin protect rodents against diabetic nephropathy by downregulating NAD(P)H oxidase (Q42945864)

11 November 2017

Bilirubin and biliverdin protect rodents against diabetic nephropathy by downregulating NAD(P)H oxidase (English)

1 reference

11 November 2017

1 reference

Masakazu Fujii

1

1 reference

11 November 2017

Toyoshi Inoguchi

2

1 reference

11 November 2017

Shuji Sasaki

3

1 reference

11 November 2017

Yasutaka Maeda

4

1 reference

11 November 2017

Jing Zheng

5

1 reference

11 November 2017

Kunihisa Kobayashi

6

1 reference

11 November 2017

Ryoichi Takayanagi

7

1 reference

11 November 2017

language of work or name

English

0 references

publication date

4 August 2010

1 reference

11 November 2017

1 reference

11 November 2017

78

1 reference

11 November 2017

905-919

1 reference

11 November 2017

9

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.2010.265

11 November 2017

0 references

cites work

Role of oxidative stress in development of complications in diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.265

7 January 2021

Free radicals and diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.265

7 January 2021

DNA damage in the kidneys of diabetic rats exhibiting microalbuminuria

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.265

7 January 2021

Accumulation of 8-hydroxy-2'-deoxyguanosine and mitochondrial DNA deletion in kidney of diabetic rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.265

7 January 2021

Protein glycation and oxidative stress in diabetes mellitus and ageing

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.265

7 January 2021

Bilirubin is an antioxidant of possible physiological importance

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.265

7 January 2021

Induction of haem oxygenase as a defence against oxidative stress

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.265

7 January 2021

Heme oxygenase and the cardiovascular-renal system

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.265

7 January 2021

Heme oxygenase and atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.265

7 January 2021

Bilirubin inhibits the activation of superoxide-producing NADPH oxidase in a neutrophil cell-free system

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.265

7 January 2021

Bilirubin decreases nos2 expression via inhibition of NAD(P)H oxidase: implications for protection against endotoxic shock in rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.265

7 January 2021

High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.265

7 January 2021

Mechanisms underlying endothelial dysfunction in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.265

7 January 2021

Vascular NADH oxidase is involved in impaired endothelium-dependent vasodilation in OLETF rats, a model of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.265

7 January 2021

Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.265

7 January 2021

Relationship between Gilbert syndrome and prevalence of vascular complications in patients with diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.265

7 January 2021

Validation of lucigenin (bis-N-methylacridinium) as a chemilumigenic probe for detecting superoxide anion radical production by enzymatic and cellular systems

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.265

7 January 2021

Statin attenuates high glucose-induced and diabetes-induced oxidative stress in vitro and in vivo evaluated by electron spin resonance measurement

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.265

7 January 2021

Vascular NAD(P)H oxidases: specific features, expression, and regulation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.265

7 January 2021

A novel superoxide-producing NAD(P)H oxidase in kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.265

7 January 2021

Identification of renox, an NAD(P)H oxidase in kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.265

7 January 2021

Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibity by interventive insulin treatment

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.265

7 January 2021

Evidence for contribution of vascular NAD(P)H oxidase to increased oxidative stress in animal models of diabetes and obesity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.265

7 January 2021

Pitavastatin ameliorates albuminuria and renal mesangial expansion by downregulating NOX4 in db/db mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.265

7 January 2021

Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.265

7 January 2021

Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.265

7 January 2021

NAD(P)H oxidase activation: a potential target mechanism for diabetic vascular complications, progressive beta-cell dysfunction and metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.265

7 January 2021

Translocation of Glomerular p47phox and p67phox by Protein Kinase C-β Activation Is Required for Oxidative Stress in Diabetic Nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.265

7 January 2021

Serum bilirubin and risk of ischemic heart disease in middle-aged British men

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.265

7 January 2021

Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.265

7 January 2021

Serum total bilirubin level, prevalent stroke, and stroke outcomes: NHANES 1999-2004.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.265

7 January 2021

Relationship of serum bilirubin concentrations to kidney function and albuminuria in the United States adult population. Findings from the National Health and Nutrition Examination Survey 2001-2006.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.265

7 January 2021

Melatonin decreases neurovascular oxidative/nitrosative damage and protects against early increases in the blood-brain barrier permeability after transient focal cerebral ischemia in mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.265

7 January 2021

A new method for large scale isolation of kidney glomeruli from mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.265

7 January 2021

Identifiers

DOI

10.1038/KI.2010.265

1 reference

11 November 2017

1 reference